Tags |
|
|
Links |
|
|
Just Answers - Realistic Investing Expectations
Over the long term stocks have provided us with great average return results. But this average return masks a gr
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
eat deal of volatility, because returns have fluctuated within a very wide band.
This extreme volatility is the
This extreme volatility is the
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
chief risk of investing in stocks, but it is a risk that tends to recede from investors' memories after a lengt
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
hy period of generally rising stock prices.
Those investors new to investing in stocks may underestimate the vo
Those investors new to investing in stocks may underestimate the vo
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
latility of stocks because volatility has been muted in recent years.
Time greatly reduces, but certainly does
Time greatly reduces, but certainly does
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
not eliminate the volatility in returns from stocks. On the other hand, there is no guarantee that you will earn
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
above average returns even if you hold stocks for two decades or more.
Investors who are relatively new to inv
Investors who are relatively new to inv
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
esting in stocks may benefit from some perspective about bear markets. During the bear markets, Indexes declined
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
an average of 25-35%. Although the average bear market lasted a little longer than 12 months, it took an averag
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
e of almost 20 months for the Indexes to return to the levels achieved before the market downturns.
Although no
Although no
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
one can reliably predict the timing of bear markets (or bull markets, for that matter), a prudent investor shou
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ld understand the extent to which stock prices can decline and should be prepared to "ride out" these periods wh
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
en they occur.
The big danger from bear markets is that investors will sell at or near the bottom of the downtu
The big danger from bear markets is that investors will sell at or near the bottom of the downtu
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
rn. Those who got out of stocks missed an extraordinary rebound in stock market performance.
Since risk is ines
Since risk is ines
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
capable when investing in stocks, perhaps the greatest risk is that you will never invest in stocks because you
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
can never be sure when is "the right time" to invest.
Uncertainty is a permanent feature of the investing lands
Uncertainty is a permanent feature of the investing lands
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
cape, and trying to discern the ideal time to invest is almost always a futile exercise.
Don't be swayed by mar
Don't be swayed by mar
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ket fluctuations or the opinions and predictions from market analysts and forecasters!
Your investment strategy
Your investment strategy
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
and expectations should all be based on your personal objectives, time horizon, risk tolerance and financial si
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
tuation.
It should not be determined by the direction of the financial markets or the opinions of "The Experts!
It should not be determined by the direction of the financial markets or the opinions of "The Experts!
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.justanswers.org.ua/article/104546/justanswers-Realistic-Investing-Expectations.html">Realistic Investing Expectations</a>
BB link (for phorums):
[url=http://www.justanswers.org.ua/article/104546/justanswers-Realistic-Investing-Expectations.html]Realistic Investing Expectations[/url]
Related Articles:
The Case Of The Duplicate Freaky Email Marketing Message
Is it Time Consuming to Launch Your Profitable Internet Business? Here's an Instant Solution
Bookmark it:
|